Neurology Devices are specialized surgical devices used for the treatment of diseases or conditions of Central Nervous System (CNS) and spine. Intracranial Pressure (ICP) monitoring devices are medical devices used to measure pressure within the skull in patients with neurological conditions that can cause increased intracranial pressure. The External Ventricular Drainage (EVD) and Microtransducer devices are covered under this market. GlobalData uses proprietary data and analytics to provide a comprehensive report on the icp monitoring devices market in France. Buy the latest report here.

In 2023, GlobalData’s Market Model methodology determined that the leading player in the icp monitoring devices market in France was Integra LifeSciences followed by Medtronic, Raumedic, Natus Medical, Spiegelberg, Sophysa and Proteses.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

The EVD is a kit along with a small tube surgically inserted that allows the temporary drainage of Cerebrospinal Fluid (CSF) from the ventricles of the brain, which helps to relieve intracranial pressure. Microtransducer devices are primarily used for measuring Intracranial Pressure.

The icp monitoring devices market in France can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size icp monitoring devices in France, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.